Table 1.

Cell Viability to UV and Therapeutic Compounds

Cell typesMTT/trypan blue exclusion assay
GM637XP30RO
UV (J/m2)[11.7 ± 0.5][5.0 ± 0.4]
Camptothecin (nmol/L)4.6 ± 0.1 (8.4 ± 0.3)4.0 ± 0.1 (6.6 ± 0.3)
dC (μmol/L)>100>100
AraC (nmol/L)1,536 ± 53 [800 ± 56] (1,177 ± 64)525 ± 20 [265 ± 45] (296 ± 19)
Gemcitabine (nmol/L)4.8 ± 0.2 [3.4 ± 0.1] (4.8 ± 0.1)2.3 ± 0.2 [1.7 ± 0.2] (2.0 ± 0.1)
Cisplatin (nmol/L)1,089 ± 11 (1,242 ± 62)381 ± 4 (462 ± 13)
Gemcitabine (2 nmol/L)/cisplatin (nmol/L)668 ± 20 (673 ± 45)47 ± 3 (23.1 ± 4)
  • NOTE: Data in brackets [] or () are results obtained from clonogenic assay or trypan blue exclusion assay, respectively.